liraglutide, semaglutide, and exenatide cross the placenta, which raises concerns about potential impacts on fetal development
Nonclinical Toxicology 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility In a 2-year carcinogenicity study in CD-1 mice, subcutaneous doses of 0.3, 1 and 3 mg/kg/day [9-, 33- and 113- fold the maximum recommended human dose (MRHD) of semaglutide tablet 14 mg, based on AUC] were administered to the males, and 0.1, 0.3 and 1 mg/kg/day (3-, 9- and 33-fold MRHD) were administered to the females
Read More Safety Information/Precaution Always keep the lid tightly sealed
Hair loss concerns have emerged in community reports, mirroring patterns seen with rapid weight loss from any cause
Compounded semaglutide costs $299 per month
Which triglyceride change does the article attribute to semaglutide